Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, Campani V, Nele V, Balmas E, Chontorotzea T, Fontana S, Digiovanni S, Alice Barbu F, Astanina E, Jafari N, Chiara Salaroglio I, Kopecka J, De Rosa G, Mohr T, Bertero A, Righi L, Novello S, Vittorio Scagliotti G, Bussolino F, Riganti C. Akman M, et al. Among authors: merlini a. J Exp Clin Cancer Res. 2024 Aug 29;43(1):244. doi: 10.1186/s13046-024-03170-0. J Exp Clin Cancer Res. 2024. PMID: 39198838 Free PMC article. No abstract available.
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality.
Farinea G, Crespi V, Listì A, Righi L, Bironzo P, Merlini A, Malapelle U, Novello S, Scagliotti GV, Passiglia F. Farinea G, et al. Among authors: merlini a. J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16. J Thorac Oncol. 2023. PMID: 37331604 Free article. Review.
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, Campani V, Nele V, Balmas E, Chontorotzea T, Fontana S, Digiovanni S, Barbu FA, Astanina E, Jafari N, Salaroglio IC, Kopecka J, De Rosa G, Mohr T, Bertero A, Righi L, Novello S, Scagliotti GV, Bussolino F, Riganti C. Akman M, et al. Among authors: merlini a. J Exp Clin Cancer Res. 2024 Aug 7;43(1):219. doi: 10.1186/s13046-024-03142-4. J Exp Clin Cancer Res. 2024. PMID: 39107857 Free PMC article.
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment.
Picca F, Giannotta C, Tao J, Giordanengo L, Munir HMW, Botta V, Merlini A, Mogavero A, Garbo E, Poletto S, Bironzo P, Doronzo G, Novello S, Taulli R, Bersani F. Picca F, et al. Among authors: merlini a. Int J Mol Sci. 2024 Oct 9;25(19):10823. doi: 10.3390/ijms251910823. Int J Mol Sci. 2024. PMID: 39409152 Free PMC article. Review.
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
Giraudo L, Cattaneo G, Gammaitoni L, Iaia I, Donini C, Massa A, Centomo ML, Basiricò M, Vigna E, Pisacane A, Picciotto F, Berrino E, Marchiò C, Merlini A, Paruzzo L, Poletto S, Caravelli D, Biolato AM, Bortolot V, Landoni E, Ventin M, Ferrone CR, Aglietta M, Dotti G, Leuci V, Carnevale-Schianca F, Sangiolo D. Giraudo L, et al. Among authors: merlini a. J Exp Clin Cancer Res. 2023 Nov 22;42(1):310. doi: 10.1186/s13046-023-02884-x. J Exp Clin Cancer Res. 2023. PMID: 37993874 Free PMC article.
94 results